Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/16/2011 | WO2011071931A2 Rna preparations comprising purified modified rna for reprogramming cells |
06/16/2011 | WO2011071923A2 Multi-sample indexing for multiplex genotyping |
06/16/2011 | WO2011071859A1 Method and composition to increase radiation-induced tumor therapeutic effects |
06/16/2011 | WO2011071632A2 Modified insm1-promoter for neuroendocrine tumor therapy and diagnostics |
06/16/2011 | WO2011071574A2 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus |
06/16/2011 | WO2011071476A2 Compositions and methods for engineering cells |
06/16/2011 | WO2011071232A1 Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single cpg site in ttp promoter and treatment of cancers by regulating its epigenetic status |
06/16/2011 | WO2011071147A1 Novel expression vector, and process for production of protein using the vector |
06/16/2011 | WO2011071099A1 Anticancer anti-mortalin peptide antibodies |
06/16/2011 | WO2011071078A1 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct |
06/16/2011 | WO2011071058A1 Preparation method for optically active 2-hydroxycycloalkane carboxylic acid ester |
06/16/2011 | WO2011071050A1 Stomate-increasing agent, polypeptide, method for increasing number and/or density of stomates in plant, and method for increasing yield of plant |
06/16/2011 | WO2011071046A1 Probe for detecting polymorphism in disease-associated gene, and use thereof |
06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
06/16/2011 | WO2011071027A1 Rna interference molecule capable of inhibiting expression of socs3 protein encoded by socs3 gene, and use thereof |
06/16/2011 | WO2011071021A1 Tag peptide |
06/16/2011 | WO2011070776A1 Method and device for synthesizing protein from dna molecule captured in microchamber |
06/16/2011 | WO2011070533A1 Peptides and their derivatives inhibiting extracellular release of hiv-1 tat protein and hiv-1 replication |
06/16/2011 | WO2011070405A1 An expression vector carrying scaffold/matrix attachment region(s) |
06/16/2011 | WO2011070150A1 Novel targets for the treatment of proliferative diseases |
06/16/2011 | WO2011069993A1 Citrullination specific phage display |
06/16/2011 | WO2011069953A1 Methods for increasing the resistance of plants to fungi by silencing the fungal smt1-gene |
06/16/2011 | WO2011069587A1 Lyophilization of nucleic acids in lactate-containing solutions |
06/16/2011 | WO2011069586A1 Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids |
06/16/2011 | WO2011069562A1 Human papillomavirus like structures produced in a non-fermentative system based on insect larva |
06/16/2011 | WO2011069529A1 Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids |
06/16/2011 | WO2011069528A1 Lyophilization of nucleic acids in lactate-containing solutions |
06/16/2011 | WO2011069487A2 Dna aptamers that specifically bind to the soluble interleukin-6 receptor |
06/16/2011 | WO2011069486A1 Rna aptamers that specifically bind to the soluble interleukin-6 receptor |
06/16/2011 | WO2011069459A1 Seed-specific expression vector and its construction methods and applications |
06/16/2011 | WO2011069280A1 Antimicrobial pexiganan analogue and preparation process thereof |
06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
06/16/2011 | WO2011069200A1 Hyperprimers |
06/16/2011 | WO2011069182A1 Compositions comprising zinc finger domains and uses therefor |
06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
06/16/2011 | WO2011042516A3 Expression system |
06/16/2011 | WO2011039631A3 Expression of meningococcal fhbp polypeptides |
06/16/2011 | WO2011034690A3 Centroid markers for image analysis of high density clusters in complex polynucleotide sequencing |
06/16/2011 | WO2011028494A3 Label-free sensing of pna-dna complexes using nanopores |
06/16/2011 | WO2011028344A3 Interleukin-1 receptor antagonist compositions and methods of making and using same |
06/16/2011 | WO2011024146A3 Adam12 inhibitors and their use against inflammation-induced fibrosis |
06/16/2011 | WO2011022357A3 Fast acting snare-cleaving enzymes |
06/16/2011 | WO2011020529A3 Antibodies for the detection of integrin complexes in ffpe material |
06/16/2011 | WO2011017596A3 Compositions and methods for identifying and detecting sites of translocation and dna fusion junctions |
06/16/2011 | WO2011017107A3 Microbubble assisted viral delivery |
06/16/2011 | WO2011011733A3 Factor replacement therapy |
06/16/2011 | WO2011006161A3 Compositions and methods for diagnosing and treating macular degeneration |
06/16/2011 | WO2011002977A3 Genetically encoded photomanipulation of protein and peptide activity |
06/16/2011 | WO2010117860A3 Microrna signature to predict prognosis in heart failure |
06/16/2011 | WO2010117465A3 Uses for long polar fimbriae genes of pathogenic escherichia coli strains |
06/16/2011 | WO2007070483A9 Micrornas that regulate muscle cell proliferation and differentiation |
06/16/2011 | US20110145954 Plants Having Improved Growth Characteristics and Method for Making the Same |
06/16/2011 | US20110145953 Marker mapping and resistance gene associations in soybean |
06/16/2011 | US20110145951 Transgenic sweet sorghum with altered lignin composition and process of preparation thereof |
06/16/2011 | US20110145949 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
06/16/2011 | US20110145948 Transgenic Plants Comprising as Transgene a Phosphatidate Cytidylyltransferase |
06/16/2011 | US20110145947 Plant Expression Vector Expressing Auxin Synthesis Related Gene and the Use Thereof in Improving Cotton Fiber Trait |
06/16/2011 | US20110145946 Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
06/16/2011 | US20110145945 Nematode-Resistant Transgenic Plants |
06/16/2011 | US20110145941 Antibodies and derivatives thereof |
06/16/2011 | US20110145940 Tal effector-mediated dna modification |
06/16/2011 | US20110145938 Method for generating monoclonal antibodies that recognize progenitor cells |
06/16/2011 | US20110144317 Mutants of glycoside hydrolases and uses thereof for synthesizing complex oligosaccharides and disaccharide intermediates |
06/16/2011 | US20110144313 Membrane fusion proteins derived from reovirus |
06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
06/16/2011 | US20110144187 Aptamer inhibition of thrombus formation |
06/16/2011 | US20110144186 Ssx-2 peptides presented by hla class ii molecules |
06/16/2011 | US20110144185 Rna antagonists targeting hsp27 |
06/16/2011 | US20110144183 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
06/16/2011 | US20110144182 Treatment of surgical adhesions |
06/16/2011 | US20110144025 Methods of Reducing Hemorrhage Due to Surgical Procedure |
06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
06/16/2011 | US20110144013 VEGF-D Mutants and Their Use |
06/16/2011 | US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
06/16/2011 | US20110144001 Highly bridged peptides from actinomadura namibiensis |
06/16/2011 | US20110143995 Novel anti-allergic agents |
06/16/2011 | US20110143443 Isolsted Monoclonal - Associated Protein Tau and Kit |
06/16/2011 | US20110143441 Methods of Reprogramming Animal Somatic Cells |
06/16/2011 | US20110143440 Mutations caused by activation-induced cytidine deaminase |
06/16/2011 | US20110143434 Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
06/16/2011 | US20110143428 Anti-vegf-c antibodies and methods using same |
06/16/2011 | US20110143424 Recombinant influenza viruses for vaccines and gene therapy |
06/16/2011 | US20110143422 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
06/16/2011 | US20110143421 Novel protease and use thereof |
06/16/2011 | US20110143418 Compositions and methods relating to orthogonal mrna pairs |
06/16/2011 | US20110143408 Zymomonas with improved arabinose utilization |
06/16/2011 | US20110143406 Novel (S,S) -Butanediol Dehydrogenase, Gene for the Same, and Use of the Same |
06/16/2011 | US20110143400 Sirna and methods of manufacture |
06/16/2011 | US20110143399 Dna joining method |
06/16/2011 | US20110143394 Methods and Means for Metabolic Engineering and Improved Product Formation by Micro-Organisms |
06/16/2011 | US20110143377 Protein fragments of virB10 and sero-detection of anaplasma phagocytophium |
06/16/2011 | US20110143362 Method for identification of protease activity inhibitors and assaying the presence of protease activity |
06/16/2011 | US20110143352 Methods for the Reduction of Stutter in Microsatellite Amplification |
06/16/2011 | US20110143350 Primers and methods for the detection and discrimination of nucleic acids |
06/16/2011 | US20110143346 Cotton event mon15985 and compositions and methods for detection thereof |
06/16/2011 | US20110142986 Transconjugants of lactic acid bacteria |
06/16/2011 | US20110142921 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
06/16/2011 | US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
06/16/2011 | US20110142880 Lentivirus-based immunogenic vectors |